The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, sponsors Neuroprotection Exploratory Trials in Parkinson’s Disease (NET-PD). NET-PD was a series of clinical research studies conducted at more than 50 centers across the country in an effort to find drugs to slow the progression of Parkinson’s.
Recruitment for the pilot NET-PD studies is now complete, and testing of the potential neuroprotective agents is underway. Compounds that appear promising in this pilot phase may have been evaluated in larger, more definitive Phase III trials. Furthermore, if additional neuroprotective agents show sufficient promise, it is also possible that additional pilot studies may be developed.
Participating in a clinical study allows you to play an active role in developing future treatments for diseases. For current studies please visit clinicaltrials.gov.
For more information about Parkinson’s disease research, visit the NINDS PD research page.